Runnymede Capital Advisors »

Fibrobiologics shares owned by Runnymede Capital Advisors

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Runnymede Capital Advisors from 13F filings

Historical chart of Runnymede Capital Advisors investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Runnymede Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Runnymede Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.5k 10k 0.55

More positions owned by Runnymede Capital Advisors

Proshares Ultra Technology Etf Uit Exchange Traded (ROM)
Invsc Qqq Trust Srs 1 Etf Uit Exchange Traded (QQQ)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Ishares Us Technology Etf Uit Exchange Traded (IYW)
Alphabet Inc Class A Common Stock (GOOGL)
Palo Alto Networks Common Stock (PANW)
Ishares S&p 100 Etf Uit Exchange Traded (OEF)
Micron Technology Common Stock (MU)
Blackstone Common Stock (BX)
Lam Resh Corp Common Stock (LRCX)
Marathon Pete Corp Common Stock (MPC)
Ishares Expanded Tech Stw Sctr Etf Uit Exchange Traded (IGV)

View all positions for Runnymede Capital Advisors

Top funds holding Fibrobiologics

Vanguard Group
Yorkville Advisors Global
Millennium Management
BlackRock
Landscape Capital Management
Gts Securities
Cascade Financial Partners
Geode Capital Management
Citadel Advisors
HPM Partners
State Street Corporation
Optivise Advisory Services
Requisite Capital Management
Wiley Bros.-aintree Capital
American Institute for Advanced Investment Management

View all funds holding Fibrobiologics